Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When to start antiretroviral therapy.

Cunlin Wang1, Saba W Masho, Daniel E Nixon

  • 1Medical College of Virginia Campus, Virginia Commonwealth University, 1000 East Clay Street, Richmond, VA 23298, USA. cwang@vcu.edu

Current HIV/AIDS Reports
|April 13, 2006
PubMed
Summary

Early treatment for human immunodeficiency virus (HIV) offers significant benefits, including immune preservation and reduced transmission. Advances in antiretroviral drugs and adherence strategies are overcoming challenges to early HIV therapy initiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

D-DARTS: an alternative method for NaV1.5 affinity molecules identification based on dual-drug affinity responsive target stability.

Bioorganic & medicinal chemistry·2025
Same author

Menisoxoisoaporphine A, a novel oxoisoaporphine alkaloid from Menispermi Rhizoma, inhibits inflammation by targeting PDE4B.

Frontiers in pharmacology·2024
Same author

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial.

JAMA oncology·2024
Same author

Drive time to care and retention in HIV care: Rural-urban differences among Medicaid enrollees in the United States South.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2024
Same author

Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers.

Clinical and translational science·2024
Same author

Brief Report: Physician Reimbursement and Retention in HIV Care: Racial Disparities in the US South.

Journal of acquired immune deficiency syndromes (1999)·2022

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • The optimal timing for initiating antiretroviral therapy (ART) in patients with human immunodeficiency virus (HIV) remains a subject of debate in current medical literature.
  • While controversial, emerging evidence suggests potential benefits of early ART initiation during primary HIV infection.

Purpose of the Study:

  • To review the evidence supporting early HIV treatment initiation.
  • To discuss the challenges associated with long-term management of early ART.
  • To evaluate how new advancements are shifting the balance towards earlier treatment.

Main Methods:

  • Literature review of studies on HIV treatment initiation timing.
  • Analysis of benefits of early ART, including immune function, viral suppression, and transmission reduction.

Related Experiment Videos

  • Examination of challenges such as drug toxicities, adherence, and resistance.
  • Assessment of the impact of novel antiretroviral drugs, simplified regimens, and adherence interventions.

    • Main Results:

    • Early ART may preserve immune function, suppress viral replication, and reduce clinical progression and HIV transmission.
    • Long-term management challenges include potential toxicities, adherence difficulties, and the development of drug resistance.
    • Newer antiretroviral drugs, simplified treatment regimens, and adherence support strategies like directly observed treatment are mitigating these challenges.

    Conclusions:

    • Advancements in antiretroviral therapy and patient management strategies are increasingly supporting the initiation of treatment early in the course of HIV infection.
    • The benefits of early intervention, including improved patient outcomes and reduced transmission, are becoming more attainable despite historical management challenges.